Globus Medical (GMED) PT Raised to $60 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $73.33 --0%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Globus Medical (NYSE: GMED) to $60.00 (from $58.00) while maintaining a Hold rating.
You May Also Be Interested In
- Targa Resources (TRGP) PT Lowered to $335 at Stifel Amid L&T Segment Operating Margin Decline
- ONEOK Inc (OKE) PT Lowered to $100 at Stifel on Lower ROIC Forecast
- Sunrun (RUN) PT Lowered to $7 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
